Sawai Group Holdings Co., Ltd. (TYO:4887)
2,062.00
-3.50 (-0.17%)
Feb 19, 2025, 3:30 PM JST
Sawai Group Holdings Revenue
Sawai Group Holdings had revenue of 55.34B JPY in the quarter ending December 31, 2024, with 13.72% growth. This brings the company's revenue in the last twelve months to 184.01B, down -0.70% year-over-year. In the fiscal year ending March 31, 2024, Sawai Group Holdings had annual revenue of 176.86B, down -11.72%.
Revenue (ttm)
184.01B
Revenue Growth
-0.70%
P/S Ratio
1.40
Revenue / Employee
52.85M
Employees
3,482
Market Cap
239.90B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 176.86B | -23.48B | -11.72% |
Mar 31, 2023 | 200.34B | 6.53B | 3.37% |
Mar 31, 2022 | 193.82B | 6.60B | 3.52% |
Mar 31, 2021 | 187.22B | 4.68B | 2.56% |
Mar 31, 2020 | 182.54B | -1.80B | -0.98% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,170.61B |
Takeda Pharmaceutical Company | 4,579.02B |
Daiichi Sankyo Company | 1,795.99B |
HOYA Corporation | 837.44B |
Terumo | 1,011.15B |
Otsuka Holdings | 2,329.86B |
Astellas Pharma | 1,867.63B |
Olympus | 993.33B |